Medbelle raises €6 Mn in Series A funding round for digital hospital
Category: #health  By Pankaj Singh  Date: 2019-04-16
  • share
  • Twitter
  • Facebook
  • LinkedIn

Medbelle raises €6 Mn in Series A funding round for digital hospital

Medtech startup Medbelle is reportedly building the first-ever digital hospital in the world, designed to supports patients through every step, starting from signup to aftercare. As per trusted sources, more than 30,000 people in the UK have already used the service, while the founders aim to entice 144,000 more users by 2020.

The London-based startup has reportedly secured €6 million in a Series A funding to expedite the digitization of the patient journey. The funding round was headed by signals Venture Capital, and included participants like Mutschler Ventures, Talis Capital, Cavalry Ventures, and IBB Beteiligungsgesellschaft, cited credible sources.

The company’s three-layered digital hospital model comprising Medbelle Care, Medbelle Platform, and Medbelle Operating System gives control to the patients and provides healthcare specialists access to an integrated suite of management tools encompassing the entire treatment journey, starting from the first consultation to payment, post-operative care, and patient follow-up.

According to sources familiar with the process, patients can book their procedure via Medbelle, which gives them access to leading medical professionals and advanced operating facilities, with all the necessary details taken care of by the platform. The Medbelle service is intended to save patients time and money allowing them to take advantage of the best treatments & facilities available. Once registered, all aspects of a patient’s treatment are available through a single and simple web portal and app, or via their personal Medbelle Care Adviser.

Concurrently, the Medbelle Operating System makes sure healthcare providers can make the most of their valuable resources and time. It allows medical professionals, hospitals, and staff to work more efficiently and releases the burden of unnecessary and unproductive administrative tasks, reported sources.

The investment will empower Medbelle to initiate the next phase of its launch and given the UK private healthcare sector’s estimation to reach $13.8 billion by the end of 2023, it’s a market opportunity that is extremely attractive to investors, reported sources.
 



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
By Pankaj Singh

While top-notch companies are racing to develop a vaccine for COVID-19, it looks like the United States has secured almost all of the world’s supply of interim drug remdesivir to treat patients with COVID-19.

...

Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
By Pankaj Singh

Bharat Biotech International, a leading Indian biotechnology company, has reportedly announced that its potential coronavirus vaccine, Covaxin, has received Drug Controller General of India (DCGI) approval to start hum...

Seattle Genetics reveals positive data from tisotumab vedotin trial
Seattle Genetics reveals positive data from tisotumab vedotin trial
By Pankaj Singh

Seattle Genetics, Inc., a renowned biotechnology firm that focuses on developing antibody-based cancer treatments, has recently revealed positive topline data from its Phase 2 clinical trial (innovaTV 204) assessing ti...